TYCC
PFE icon

Texas Yale Capital Corp’s Pfizer PFE Stock Holding History

Texas Yale Capital Corp’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,125
Closed -$295K – 471
2024
Q4 		$295K Sell
11,125
-6,879
-38% -$187K 0.01% 391
2024
Q3 		$521K Sell
18,004
-2,782
-13% -$81.2K 0.02% 330
2024
Q2 		$582K Sell
20,786
-1,805
-8% -$49.7K 0.03% 305
2024
Q1 		$627K Sell
22,591
-1,200
-5% -$33.3K 0.03% 301
2023
Q4 		$685K Sell
23,791
-18,856
-44% -$570K 0.03% 288
2023
Q3 		$1.41M Sell
42,647
-452
-1% -$16K 0.06% 196
2023
Q2 		$1.58M Buy
43,099
+1,308
+3% +$50.9K 0.07% 190
2023
Q1 		$1.71M Buy
41,791
+213
+0.5% +$9.2K 0.09% 188
2022
Q4 		$2.13M Buy
41,578
+76
+0.2% +$3.64K 0.12% 152
2022
Q3 		$1.82M Sell
41,502
-1,450
-3% -$70.5K 0.12% 157
2022
Q2 		$2.25M Sell
42,952
-760
-2% -$38.7K 0.15% 136
2022
Q1 		$2.26M Buy
43,712
+760
+2% +$39.4K 0.12% 154
2021
Q4 		$2.54M Buy
42,952
+635
+2% +$31.5K 0.13% 142
2021
Q3 		$1.82M Hold
42,317
– – 0.1% 178
2021
Q2 		$1.66M Sell
42,317
-100
-0.2% -$3.89K 0.09% 187
2021
Q1 		$1.54M Sell
42,417
-6,300
-13% -$224K 0.1% 187
2020
Q4 		$1.79M Sell
48,717
-2,631
-5% -$96.5K 0.12% 162
2020
Q3 		$1.79M Hold
51,348
– – 0.14% 145
2020
Q2 		$1.59M Sell
51,348
-10,102
-16% -$343K 0.13% 153
2020
Q1 		$1.9M Sell
61,450
-24,291
-28% -$828K 0.19% 111
2019
Q4 		$3.19M Buy
85,741
+1,031
+1% +$36.7K 0.22% 89
2019
Q3 		$2.89M Sell
84,710
-7,064
-8% -$257K 0.21% 99
2019
Q2 		$3.77M Sell
91,774
-96,072
-51% -$3.81M 0.28% 70
2019
Q1 		$7.57M Buy
187,846
+92,890
+98% +$3.72M 0.3% 68
2018
Q4 		$3.93M Buy
94,956
+4,485
+5% +$186K 0.36% 56
2018
Q3 		$3.78M Buy
90,471
+2,529
+3% +$97.4K 0.31% 64
2018
Q2 		$3.03M Buy
87,942
+1,323
+2% +$45.2K 0.26% 81
2018
Q1 		$2.92M Sell
86,619
-843
-1% -$29K 0.25% 75
2017
Q4 		$3.01M Sell
87,462
-103
-0.1% -$3.51K 0.26% 76
2017
Q3 		$2.97M Sell
87,565
-221
-0.3% -$7.1K 0.26% 71
2017
Q2 		$2.8M Buy
87,786
+221
+0.3% +$6.97K 0.25% 70
2017
Q1 		$2.84M Sell
87,565
-1,028
-1% -$32.4K 0.25% 68
2016
Q4 		$2.73M Buy
88,593
+56,531
+176% +$1.73M 0.26% 71
2016
Q3 		$1.03M Sell
32,062
-5,270
-14% -$176K 0.1% 185
2016
Q2 		$1.25M Sell
37,332
-1,776
-5% -$56.7K 0.12% 155
2016
Q1 		$1.1M Sell
39,108
-288
-0.7% -$8.23K 0.11% 165
2015
Q4 		$1.21M Hold
39,396
– – 0.12% 148
2015
Q3 		$1.17M Buy
39,396
+122
+0.3% +$3.91K 0.11% 157
2015
Q2 		$1.25M Buy
39,274
+1
+0% +$33 0.1% 163
2015
Q1 		$1.3M Sell
39,273
-11,583
-23% -$368K 0.1% 163
2014
Q4 		$1.5M Buy
50,856
+2,112
+4% +$60.6K 0.13% 126
2014
Q3 		$1.37M Buy
48,744
+1,320
+3% +$37K 0.13% 121
2014
Q2 		$1.33M Sell
47,424
-136
-0.3% -$3.88K 0.17% 121
2014
Q1 		$1.45M Sell
47,560
-1,221
-3% -$36.4K 0.2% 102
2013
Q4 		$1.42M Buy
48,781
+1
+0% +$29 0.22% 96
2013
Q3 		$1.33M Buy
48,780
+142
+0.3% +$3.86K 0.22% 98
2013
Q2 		$1.29M Buy
+48,638
New +$1.34M 0.23% 97

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Texas Yale Capital Corp's PFE Position: Q1 2025 in Review

Texas Yale Capital Corp sold out of Pfizer (PFE) in Q1 2025, closing a stake of 11,125 shares — an estimated $295K sold.

Texas Yale Capital Corp first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $7.57M in Q1 2019. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Texas Yale Capital Corp reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Texas Yale Capital Corp sold 11,125 Pfizer shares in Q1 2025, an estimated $295K.
  • Texas Yale Capital Corp first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
  • Texas Yale Capital Corp's Pfizer position peaked at $7.57M in Q1 2019.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Texas Yale Capital Corp's 13F filing for Q1 2025, filed 7 May 2025.